These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14702928)

  • 1. Management of acute cancer treatment-induced diarrhea.
    Stern J; Ippoliti C
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):11-6. PubMed ID: 14702928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of chemotherapy-induced diarrhea.
    Viele CS
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):2-5. PubMed ID: 14702926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for the prevention and reduction of cancer treatment-induced diarrhea.
    Anthony L
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):17-21. PubMed ID: 14702929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.
    Cascinu S; Bichisao E; Amadori D; Silingardi V; Giordani P; Sansoni E; Luppi G; Catalano V; Agostinelli R; Catalano G
    Support Care Cancer; 2000 Jan; 8(1):65-7. PubMed ID: 10650901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimotility agents for the treatment of acute noninfectious diarrhea in critically ill patients: A practice management guideline from the Eastern Association for the Surgery of Trauma.
    Bugaev N; Bhattacharya B; Chiu WC; Como JJ; Cripps MW; Ferrada P; Gelbard RB; Gondek S; Kasotakis G; Kim D; Mentzer C; Robinson BRH; Salcedo ES; Yeh DD
    J Trauma Acute Care Surg; 2019 Oct; 87(4):915-921. PubMed ID: 31574060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB; Gilmore CE; Dix SP; Lin LS; Topping DL; Davidson TG; Holland HK; Wingard JR
    Am J Hematol; 1995 Nov; 50(3):167-72. PubMed ID: 7485077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of radiation- and chemoradiation-induced diarrhea.
    Gwede CK
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):6-10. PubMed ID: 14702927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN; Yavuz AA; Aydin F; Can G; Kavgaci H
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):195-202. PubMed ID: 12182992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of chemotherapy induced diarrhea].
    Schultz M; Schölmerich J; Kullmann F
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nurse's role in diarrhea management.
    Hogan CM
    Oncol Nurs Forum; 1998 Jun; 25(5):879-86. PubMed ID: 9644704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea.
    Palmer KR; Corbett CL; Holdsworth CD
    Gastroenterology; 1980 Dec; 79(6):1272-5. PubMed ID: 7002706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and oncology nursing.
    Calzone KA; Masny A
    Semin Oncol Nurs; 2004 Aug; 20(3):178-85. PubMed ID: 15491027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V; Koumakis G; Vassilomanolakis M; Demiri M; Efremidis AP
    Support Care Cancer; 2001 Jun; 9(4):258-60. PubMed ID: 11430421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
    Gebbia V; Carreca I; Testa A; Valenza R; Curto G; Cannata G; Borsellino N; Latteri MA; Cipolla C; Florena M
    Anticancer Drugs; 1993 Aug; 4(4):443-5. PubMed ID: 8400346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical challenges: chemotherapy-induced peripheral neuropathy.
    Paice JA
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
    J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?
    de Lemos ML; Guenter J; Kletas V
    J Oncol Pharm Pract; 2018 Dec; 24(8):634-636. PubMed ID: 28714380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S
    Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH
    Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.